Atlas Trials

Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.

Clinical trial NCT02283801 · COMPLETED

Trial details

NCT number
NCT02283801
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2006-11-01
Primary completion
2007-01-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.